AAAAAA

   
Results: 1-3 |
Results: 3
A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease
Authors: Berenson, JR Vescio, R Henick, K Nishikubo, C Rettig, M Swift, RA Conde, F Von Teichert, JM
Citation: Jr. Berenson et al., A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease, CANC CYTOP, 91(1), 2001, pp. 144-154
A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease
Authors: Berenson, JR Vescio, R Henick, K Nishikubo, C Rettig, M Swift, RA Conde, F Von Teichert, JM
Citation: Jr. Berenson et al., A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease, CANCER, 91(1), 2001, pp. 144-154
Mimicking the reaction of phenylalanine ammonia lyase by a synthetic model
Authors: Rettig, M Sigrist, A Retey, J
Citation: M. Rettig et al., Mimicking the reaction of phenylalanine ammonia lyase by a synthetic model, HELV CHIM A, 83(9), 2000, pp. 2246-2265
Risultati: 1-3 |